Journal
TRANSPLANT INFECTIOUS DISEASE
Volume 15, Issue 2, Pages 111-119Publisher
WILEY
DOI: 10.1111/tid.12033
Keywords
Toll-like receptor 3; polymorphism; cirrhosis; graft failure; mortality; chronic hepatitis C; HCV; liver transplantation
Categories
Funding
- Mayo Clinic Center for Translational Science Activities
Ask authors/readers for more resources
Background Toll-like receptor 3 (TLR3) is implicated in the pathogenesis of viral diseases owing to its ability to recognize viral double-stranded RNA. We hypothesized that single nucleotide polymorphism (SNP) in TLR3 gene that impairs the function of the protein-receptor influences the outcome of hepatitis C virus (HCV) infection after liver transplantation. Methods The clinical characteristics of 611 liver recipients (HCV-infected: n=153, non-HCV-infected: n=458) were assessed to investigate the impact of TLR3 L412F SNP on transplant outcomes. Results TLR3 L412F is common, and it was significantly more prevalent among the HCV-infected cohort (57.5% vs. 45.2%, P=0.008). In a multivariate analysis, TLR3 L412F was significantly associated with chronic hepatitis C (odds ratio: 1.73, 95% confidence interval [CI]: 1.132.65, P=0.01). In an analysis that compared HCV-infected patients with wild-type versus TLR3 L412F, a marginally higher rate of allograft failure and mortality was observed in the TLR3 L412F group (44.3% vs. 30.8%, P=0.09). However, in a multivariate analysis, only donor age was significantly associated with allograft failure and mortality (relative risk: 1.04, 95% CI: 1.0071.06, P=0.02). Conclusion TLR3 L412F is significantly common in HCV-infected liver recipients, and may be associated with worse outcomes. However, larger studies are needed to determine its significant association with allograft failure and mortality after liver transplantation for chronic hepatitis C.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available